At a Glance Commentary

RATIONALE Idiopathic pulmonary fibrosis is a progressive, uniformly fatal interstitial lung disease. An acute exacerbation of idiopathic pulmonary fibrosis is an episode of acute respiratory worsening without an identifiable etiology. Occult viral infection has been proposed as a possible cause of acute exacerbation. OBJECTIVES To use unbiased genomics-based discovery methods to define the role of viruses in acute exacerbation of idiopathic pulmonary fibrosis. METHODS Bronchoalveolar lavage and serum from patients with acute exacerbation of idiopathic pulmonary fibrosis, stable disease, and acute lung injury were tested for viral nucleic acid using multiplex polymerase chain reaction, pan-viral microarray, and high-throughput cDNA sequencing. MEASUREMENTS AND MAIN RESULTS Four of forty-three patients with acute exacerbation of idiopathic pulmonary fibrosis had evidence of common respiratory viral infection (parainfluenza [n = 1], rhinovirus [n = 2], coronavirus [n = 1]); no viruses were detected in the bronchoalveolar lavage from stable patients. Pan-viral microarrays revealed additional evidence of viral infection (herpes simplex virus [n = 1], Epstein-Barr virus [n = 2], and torque teno virus [TTV] [n = 12]) in patients with acute exacerbation. TTV infection was significantly more common in patients with acute exacerbation than stable controls (P = 0.0003), but present in a similar percentage of acute lung injury controls. Deep sequencing of a subset of acute exacerbation cases confirmed the presence of TTV but did not identify additional viruses. CONCLUSIONS Viral infection was not detected in most cases of acute exacerbation of idiopathic pulmonary fibrosis. TTV was present in a significant minority of cases, and cases of acute lung injury; the clinical significance of this finding remains to be determined.

[1]  A. Wells,et al.  Acute Exacerbations of Idiopathic Pulmonary Fibrosis , 2013, Respiration.

[2]  K. Brown,et al.  A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: Aetiology and outcomes , 2010, Respirology.

[3]  A. Wells,et al.  Diffuse alveolar damage in idiopathic pulmonary fibrosis: Does aetiology matter? , 2010, Respirology.

[4]  H. Collard,et al.  Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[5]  Jong-Min Song,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome , 2010, European Respiratory Journal.

[6]  R. del Campo,et al.  Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization. , 2010, Journal of microbiological methods.

[7]  J. Derisi,et al.  Human Enterovirus 109: a Novel Interspecies Recombinant Enterovirus Isolated from a Case of Acute Pediatric Respiratory Illness in Nicaragua , 2010, Journal of Virology.

[8]  G. Raghu,et al.  Pirfenidone in idiopathic pulmonary fibrosis , 2009, European Respiratory Journal.

[9]  Jin Woo Song,et al.  Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[10]  B. Moore,et al.  Viruses as co-factors for the initiation or exacerbation of lung fibrosis , 2008, Fibrogenesis & tissue repair.

[11]  Phillip I. Tarr,et al.  Metagenomic Analysis of Human Diarrhea: Viral Detection and Discovery , 2008, PLoS pathogens.

[12]  H. Collard,et al.  Acute exacerbations of idiopathic pulmonary fibrosis. , 2007, American journal of respiratory and critical care medicine.

[13]  J. Tang,et al.  Rapid Multiplex Nested PCR for Detection of Respiratory Viruses , 2007, Journal of Clinical Microbiology.

[14]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[15]  H. Collard,et al.  Classification and Natural History of the Idiopathic Interstitial Pneumonias Who Is at Risk of Ipf? What Causes Ipf? , 2022 .

[16]  A. Nicholson,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features , 2006, European Respiratory Journal.

[17]  Gordon R Bernard,et al.  Acute respiratory distress syndrome: a historical perspective. , 2005, American journal of respiratory and critical care medicine.

[18]  Katsutoshi Nakayama,et al.  Anticoagulant therapy for idiopathic pulmonary fibrosis. , 2005, Chest.

[19]  Joseph L DeRisi,et al.  E-Predict: a computational strategy for species identification based on observed DNA microarray hybridization patterns , 2005, Genome Biology.

[20]  Mary Ellen Kitler,et al.  European Respiratory Society , 2005, International Journal of Pharmaceutical Medicine.

[21]  S. Kudoh,et al.  Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2005, American journal of respiratory and critical care medicine.

[22]  A. Boner,et al.  TT Virus in the Nasal Secretions of Children with Acute Respiratory Diseases: Relations to Viremia and Disease Severity , 2003, Journal of Virology.

[23]  J. Derisi,et al.  Microarray-based detection and genotyping of viral pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Bartolomé,et al.  TT virus replicates in stimulated but not in nonstimulated peripheral blood mononuclear cells. , 2002, Virology.

[25]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[26]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[27]  M. Bando,et al.  Infection of TT virus in patients with idiopathic pulmonary fibrosis. , 2001, Respiratory medicine.

[28]  N. Young,et al.  Prevalence of the newly described human circovirus, TTV, in United States blood donors , 2000, Transfusion.

[29]  T. Nishizawa,et al.  Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. , 1999, Virology.

[30]  H. Ishiko,et al.  Detection of a novel DNA virus (TTV) sequence in peripheral blood mononuclear cells , 1999, Journal of medical virology.

[31]  T. Pilot‐Matias,et al.  Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[34]  E. Aurelius,et al.  Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid , 1991, The Lancet.

[35]  Terry A. Welch,et al.  A Technique for High-Performance Data Compression , 1984, Computer.

[36]  H. Miyata,et al.  Torque teno virus (TTV): current status , 2007, Reviews in medical virology.

[37]  K. Ikuta,et al.  Epstein–Barr Virus DNA is Detected in Peripheral Blood Mononuclear Cells of EBV-seronegative Infants with Infectious Mononucleosis-like Symptoms , 2004, Virus Genes.

[38]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[39]  Arnold Simanowitz,et al.  international consensus statement , 2000 .